Follow-up to management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis
Can Commun Dis Rep. 1998 Aug 15;24(16):129-32.
[Article in
English,
French]
Affiliation
- 1 Toronto Hospital, University of Toronto, Department of Pharmacy.
No abstract available
MeSH terms
-
AIDS-Related Opportunistic Infections / drug therapy*
-
Anti-Bacterial Agents / adverse effects*
-
Anti-HIV Agents / therapeutic use
-
Drug Interactions
-
HIV Protease Inhibitors / adverse effects*
-
HIV Reverse Transcriptase / antagonists & inhibitors
-
Humans
-
Patient Selection
-
Reverse Transcriptase Inhibitors / therapeutic use
-
Rifamycins / adverse effects*
-
Tuberculosis / drug therapy*
Substances
-
Anti-Bacterial Agents
-
Anti-HIV Agents
-
HIV Protease Inhibitors
-
Reverse Transcriptase Inhibitors
-
Rifamycins
-
HIV Reverse Transcriptase